Toward Biomarker-Informed Trimodality Therapy (TMT) Approaches for Muscle-Invasive Bladder Cancer
Int J Radiat Oncol Biol Phys
.
2018 Dec 1;102(5):1417-1419.
doi: 10.1016/j.ijrobp.2018.07.2020.
Epub 2018 Aug 10.
Author
Kent W Mouw
1
Affiliation
1
Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: kent_mouw@dfci.harvard.edu.
PMID:
30103024
DOI:
10.1016/j.ijrobp.2018.07.2020
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers
Chemoradiotherapy
Cystectomy
Humans
Immunohistochemistry
Urinary Bladder Neoplasms*
Substances
Biomarkers